UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Macrophage activation syndrome in the era of biologic therapy

Nature reviews. Rheumatology, 2016-05, Vol.12 (5), p.259-268

2016

Volltextzugriff (PDF)

Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies

Annual review of medicine, 2015-01, Vol.66 (1), p.145-159

2015

Volltextzugriff (PDF)

Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment

Genes and immunity, 2012-06, Vol.13 (4), p.289-298

2012

Volltextzugriff (PDF)

On the Alert for Cytokine Storm: Immunopathology in COVID‐19

Arthritis & rheumatology (Hoboken, N.J.), 2020-07, Vol.72 (7), p.1059-1063

2020

Volltextzugriff (PDF)

Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

Blood, 2018-03, Vol.131 (13), p.1442-1455

2018

Volltextzugriff (PDF)

Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors

Arthritis & rheumatology (Hoboken, N.J.), 2019-11, Vol.71 (11), p.1943-1954

2019

Volltextzugriff (PDF)

Macrophage activation syndrome and cytokine-directed therapies

Best practice & research. Clinical rheumatology, 2014-04, Vol.28 (2), p.277-292

2014

Volltextzugriff (PDF)

IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome

Rheumatology (Oxford, England), 2020-02, Vol.59 (2), p.361-366

2020

Volltextzugriff (PDF)

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Annals of the rheumatic diseases, 2016-03, Vol.75 (3), p.481-489

2016

Volltextzugriff (PDF)

Macrophage activation syndrome: advances towards understanding pathogenesis

Current opinion in rheumatology, 2010-09, Vol.22 (5), p.561-566

2010

Volltextzugriff (PDF)

Whole‐Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis

Arthritis & rheumatology (Hoboken, N.J.), 2014-12, Vol.66 (12), p.3486-3495

2014

Volltextzugriff (PDF)

Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza

The Journal of infectious diseases, 2016-04, Vol.213 (7), p.1180-1188

2016

Volltextzugriff (PDF)

The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study

Pediatric rheumatology online journal, 2024-01, Vol.21 (Suppl 1), p.150-4, Article 150

2024

Volltextzugriff (PDF)

Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis

The Journal of clinical investigation, 2023-11, Vol.133 (22), p.1-18

2023

Volltextzugriff (PDF)

Urine S100 proteins as potential biomarkers of lupus nephritis activity

Arthritis research & therapy, 2017-10, Vol.19 (1), p.242-242, Article 242

2017

Volltextzugriff (PDF)

Systemic JIA: new developments in the understanding of the pathophysiology and therapy

Best practice & research. Clinical rheumatology, 2009-10, Vol.23 (5), p.655-664

2009

Volltextzugriff (PDF)

Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease

Frontiers in immunology, 2018-12, Vol.9, p.2995-2995

2018

Volltextzugriff (PDF)

Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

Arthritis research & therapy, 2005-01, Vol.7 (1), p.R30-R37, Article R30

2005

Volltextzugriff (PDF)

The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA

Pediatric rheumatology online journal, 2024-01, Vol.21 (Suppl 1), p.87-5, Article 87

2024

Volltextzugriff (PDF)

Genetic Defects in Cytolysis in Macrophage Activation Syndrome

Current rheumatology reports, 2014-09, Vol.16 (9), p.439-439, Article 439

2014

Volltextzugriff (PDF)

Genetics of Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

Advances in experimental medicine and biology, 2024, Vol.1448, p.121

Grom, Alexei A

2024

Volltextzugriff (PDF)

Well-being and depression during the COVID-19 pandemic

European journal of public health, 2021-10, Vol.31 (Supplement_3)

2021

Volltextzugriff (PDF)

S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis

Arthritis research & therapy, 2024-06, Vol.26 (1), p.125-12, Article 125

2024

Volltextzugriff (PDF)

The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)

Arthritis & rheumatology (Hoboken, N.J.), 2023-10, Vol.75 (10), p.1714-1732

2023

Volltextzugriff (PDF)

1 – 25 von 653

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(462)
Mit Volltextzugriff
(454)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(278)
Life Sciences & Biomedicine
(241)
Humans
(206)
Rheumatology
(123)
Male
(110)
Female
(107)
Child
(92)
Biological And Medical Sciences
(63)
Animals
(53)
Arthritis
(52)
Adolescent
(51)
Child, Preschool
(51)
Medical Sciences
(51)
Pediatrics
(43)
Patients
(42)
Diseases Of The Osteoarticular System
(38)
Arthritis, Juvenile - Immunology
(37)
Adult
(35)
Arthritis, Juvenile - Genetics
(33)
Arthritis, Juvenile - Drug Therapy
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Macrophage activation syndrome in the era of biologic therapy

Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies

Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment

On the Alert for Cytokine Storm: Immunopathology in COVID‐19

Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors

Macrophage activation syndrome and cytokine-directed therapies

IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Macrophage activation syndrome: advances towards understanding pathogenesis

Whole‐Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis

Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza

The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study

Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis

Urine S100 proteins as potential biomarkers of lupus nephritis activity

The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)

Systemic JIA: new developments in the understanding of the pathophysiology and therapy

Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease

Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA

Genetic Defects in Cytolysis in Macrophage Activation Syndrome

Genetics of Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

Well-being and depression during the COVID-19 pandemic

S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis

The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)

Suchergebnisse filtern